Atlas Trials

FANLUNG-2:The Value of High-Low Mixed-Dose Radiotherapy Combined With Chemo-Immunotherapy Induction in Locally Advanced Non-Small Cell Lung Cancer

Clinical trial NCT07418866 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07418866
Sponsor
Fudan University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
NSCLC (Advanced Non-small Cell Lung Cancer)
Start date
2026-02-01
Primary completion
2028-02-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.